Beginning in July of 2018, numerous pharmaceutical drug manufacturers have all issued voluntary recalls of blood pressure and heart failure drug Valsartan. The recalls began after the U.S. Food and Drug Administration determined potent carcinogens, NDMA (N-nitrosodimethylamine) and NDEA (N-Nitrosodiethylamine), had been found in Valsartan. The recalls were expanded in August of 2018 and again in March of 2019.
The recalls include virtually every generic version of Valsartan, but do not include the brand name, Valsartan-based drugs Diovan, Entresto, Exforge, or Exforge HCT.
Our firm is currently investigating cases where individuals took Valsartan before being diagnosed with one of the following types of cancer of the digestive tract:
- Liver Cancer
- Stomach Cancer (including gastric cancer)
- Colorectal Cancer (including colon and rectal cancer)
- Intestinal Cancer
- Esophageal Cancer
- Kidney Cancer
- Pancreatic Cancer
- Uterine Cancer
If you or someone you know has been diagnosed with one of these forms of cancer after taking Valsartan, contact us online or call us at 1-866-252-3535.
Do not stop taking any medication without consulting your healthcare provider.